
-
Exxon, Chevron turn page on legal fight as profits slip
-
Prosecutors call for PSG's Achraf Hakimi to face rape trial
-
Missing Kenya football tickets blamed on govt protest fears
-
India's Krishna and Siraj rock England in series finale
-
Norris completes 'double top' in Hungary practice
-
MLB names iconic Wrigley Field as host of 2027 All-Star Game
-
Squiban doubles up at women's Tour de France
-
International crew bound for space station
-
China's Qin takes 'miracle' second breaststroke gold at swim worlds
-
Siraj strikes as India fight back in England finale
-
Brewed awakening: German beer sales lowest on record
-
Indonesia volcano belches six-mile ash tower
-
US promises Gaza food plan after envoy visit
-
Musk's X accuses Britain of online safety 'overreach'
-
France says it cannot save contraceptives US plans to destroy
-
Russian drone attacks on Ukraine hit all-time record in July
-
Stocks sink on Trump tariffs, US jobs data
-
Newcastle reject Liverpool bid for Isak: reports
-
Cracks emerge in US jobs market as Fed officials sound warning
-
Douglass dedicates world gold to stricken US after 'rough' week
-
Senegal PM unveils economic recovery plan based on domestic resources
-
China's Qin milks 'miracle' second breaststroke gold at swim worlds
-
Swiss will try to negotiate way out of stiff US tariffs
-
US job growth weaker than expected in July as unemployment rises
-
Miracle man Qin wins second worlds gold ahead of blockbuster
-
Budapest mayor questioned as a suspect over Pride march
-
Thai-Cambodian cyberwarriors battle on despite truce
-
UK top court to rule on multi-billion pound car loan scandal
-
World economies reel from Trump's tariffs punch
-
French wine industry warns of 'brutal' impact from US tariffs
-
England openers run riot in India finale after Atkinson strikes
-
China's Qin wins 'miracle' second breaststroke gold at swim worlds
-
US envoy visits Gaza sites as UN says hundreds of aid-seekers killed
-
Steenbergen wins world 100m freestyle to deny O'Callaghan
-
Stocks slide as Trump's new tariff sweep offsets earnings
-
HIV-positive Turkmen man fears deportation, torture
-
India collapse in England decider as Atkinson strikes
-
Outrage grows in France over US plan to destroy contraceptives
-
Rees-Zammit to return to rugby after NFL dream ends
-
England say injured Woakes set to miss rest of India decider
-
Bayer sets aside more cash to deal with weedkiller woes
-
Pakistan inflict more T20 misery on West Indies
-
South Korea's Yoon resists questioning by lying in underwear
-
Stocks drop as Trump's new tariff sweep offsets earnings
-
El Salvador abolishes presidential term limits, allowing another Bukele run
-
Nintendo quarterly revenue surges thanks to Switch 2
-
Swiss to try to negotiate way out of stiff US tariffs
-
British Airways owner sees profit jump on 'strong' demand
-
Sand and dust storm sweeps across southern Peru
-
Battered Wallabies determined to deny Lions a whitewash
CMSC | -0.13% | 22.82 | $ | |
BCC | -1.17% | 82.84 | $ | |
SCS | -1.22% | 10.205 | $ | |
RBGPF | 0.69% | 74.94 | $ | |
GSK | 0.57% | 37.364 | $ | |
BTI | 1.33% | 54.405 | $ | |
CMSD | 0.17% | 23.31 | $ | |
NGG | 1.74% | 71.64 | $ | |
JRI | -0.44% | 13.073 | $ | |
SCU | 0% | 12.72 | $ | |
RYCEF | -2.75% | 13.8 | $ | |
BCE | 1.31% | 23.64 | $ | |
BP | -1.34% | 31.725 | $ | |
RELX | -0.87% | 51.44 | $ | |
RIO | -0.47% | 59.49 | $ | |
AZN | 0.73% | 73.63 | $ | |
VOD | 1.1% | 10.93 | $ |

Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
P.Martin--AMWN